These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 37711753)

  • 21. Prevalence and predictors of premenstrual dysphoric disorder (PMDD) in older premenopausal women. The Harvard Study of Moods and Cycles.
    Cohen LS; Soares CN; Otto MW; Sweeney BH; Liberman RF; Harlow BL
    J Affect Disord; 2002 Jul; 70(2):125-32. PubMed ID: 12117624
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pretreatment pattern of symptom expression in premenstrual dysphoric disorder.
    Pearlstein T; Yonkers KA; Fayyad R; Gillespie JA
    J Affect Disord; 2005 Apr; 85(3):275-82. PubMed ID: 15780697
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Insomnia, Inattention and Fatigue Symptoms of Women with Premenstrual Dysphoric Disorder.
    Lin PC; Ko CH; Lin YJ; Yen JY
    Int J Environ Res Public Health; 2021 Jun; 18(12):. PubMed ID: 34201084
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The prevalence, impairment, impact, and burden of premenstrual dysphoric disorder (PMS/PMDD).
    Halbreich U; Borenstein J; Pearlstein T; Kahn LS
    Psychoneuroendocrinology; 2003 Aug; 28 Suppl 3():1-23. PubMed ID: 12892987
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changes in mood, cognitive performance and appetite in the late luteal and follicular phases of the menstrual cycle in women with and without PMDD (premenstrual dysphoric disorder).
    Reed SC; Levin FR; Evans SM
    Horm Behav; 2008 Jun; 54(1):185-93. PubMed ID: 18413151
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Premenstrual syndrome and premenstrual dysphoric disorder in adolescents.
    Itriyeva K
    Curr Probl Pediatr Adolesc Health Care; 2022 May; 52(5):101187. PubMed ID: 35534402
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictors of premenstrual impairment among women undergoing prospective assessment for premenstrual dysphoric disorder: a cycle-level analysis.
    Schmalenberger KM; Eisenlohr-Moul TA; Surana P; Rubinow DR; Girdler SS
    Psychol Med; 2017 Jul; 47(9):1585-1596. PubMed ID: 28193300
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of GABA active steroids in the female brain with a focus on the premenstrual dysphoric disorder.
    Bixo M; Johansson M; Timby E; Michalski L; Bäckström T
    J Neuroendocrinol; 2018 Feb; 30(2):. PubMed ID: 29072794
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence, incidence and stability of premenstrual dysphoric disorder in the community.
    Wittchen H -U; Becker E; Lieb R; Krause P
    Psychol Med; 2002 Jan; 32(1):119-32. PubMed ID: 11883723
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Premenstrual syndrome and premenstrual dysphoric disorder in perimenopausal women.
    Chung SH; Kim TH; Lee HH; Lee A; Jeon DS; Park J; Kim Y
    J Menopausal Med; 2014 Aug; 20(2):69-74. PubMed ID: 25371896
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Working memory deficit in premenstrual dysphoric disorder and its associations with difficulty in concentrating and irritability.
    Yen JY; Chang SJ; Long CY; Tang TC; Chen CC; Yen CF
    Compr Psychiatry; 2012 Jul; 53(5):540-5. PubMed ID: 21821238
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Emotion regulation in women with premenstrual dysphoric disorder.
    Petersen N; London ED; Liang L; Ghahremani DG; Gerards R; Goldman L; Rapkin AJ
    Arch Womens Ment Health; 2016 Oct; 19(5):891-8. PubMed ID: 27155663
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence and correlates of current suicidal ideation in women with premenstrual dysphoric disorder.
    Wikman A; Sacher J; Bixo M; Hirschberg AL; Kopp Kallner H; Epperson CN; Comasco E; Sundström Poromaa I
    BMC Womens Health; 2022 Feb; 22(1):35. PubMed ID: 35148753
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Network Pharmacology and Data Mining Approach Reveal the Medication Rule of Traditional Chinese Medicine in the Treatment of Premenstrual Syndrome/Premenstrual Dysphoric Disorder.
    Qu S; Qiao M; Wang J; Gao M; Chen D; Li S; Wei E; Guo Y
    Front Pharmacol; 2022; 13():811030. PubMed ID: 35800440
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Placebo-controlled trial comparing intermittent and continuous paroxetine in premenstrual dysphoric disorder.
    Landén M; Nissbrandt H; Allgulander C; Sörvik K; Ysander C; Eriksson E
    Neuropsychopharmacology; 2007 Jan; 32(1):153-61. PubMed ID: 17035933
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Update on research and treatment of premenstrual dysphoric disorder.
    Cunningham J; Yonkers KA; O'Brien S; Eriksson E
    Harv Rev Psychiatry; 2009; 17(2):120-37. PubMed ID: 19373620
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Daily symptom ratings for studying premenstrual dysphoric disorder: A review.
    Bosman RC; Jung SE; Miloserdov K; Schoevers RA; aan het Rot M
    J Affect Disord; 2016 Jan; 189():43-53. PubMed ID: 26406968
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The association between premenstrual dysphoric disorder and other mood disorders.
    Yonkers KA
    J Clin Psychiatry; 1997; 58 Suppl 15():19-25. PubMed ID: 9427873
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The efficiency of oral contraception containing drospirenone in treating symptoms of premenstrual syndrome or premenstrual dysphoric disorder in gyneacology practice].
    Svojanovská K
    Ceska Gynekol; 2010 Oct; 75(5):474-80. PubMed ID: 21374928
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The impact of competitive sports on menstrual cycle and menstrual disorders, including premenstrual syndrome, premenstrual dysphoric disorder and hormonal imbalances.
    Czajkowska M; Drosdzol-Cop A; Naworska B; Galazka I; Gogola C; Rutkowska M; Skrzypulec-Plinta V
    Ginekol Pol; 2020; 91(9):503-512. PubMed ID: 33030729
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.